University of Virginia and Tandem Diabetes Care Join Forces to Revolutionize Diabetes Management
The University of Virginia Center for Diabetes Technology and Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, have embarked on a multi-year research collaboration aimed at developing cutting-edge fully automated insulin delivery systems. This partnership brings together the expertise of both institutions to accelerate advancements in diabetes care and improve the lives of people with diabetes.
Combining Expertise for Innovative Solutions
The collaboration leverages the strengths of both organizations. The UVA Center for Diabetes Technology is renowned for its pioneering work in developing technology-based interventions for diabetes management, including advanced automated insulin delivery (AID) algorithms that have been successfully translated into widely used medical devices. Tandem Diabetes Care brings its expertise in insulin delivery devices, algorithm implementation, and data management to the partnership.
This collaboration builds on a long-standing relationship between the two organizations, spanning over a decade. Both institutions are committed to pushing the boundaries of diabetes technology and developing innovative solutions that can significantly enhance the lives of people with diabetes.
Advancing Automated Insulin Delivery
The research collaboration will focus on advancing automated closed-loop insulin delivery technology, often referred to as an "artificial pancreas." These systems continuously monitor blood glucose levels and automatically adjust insulin delivery to maintain optimal glucose control.
The joint effort will involve a multidisciplinary team of scientists, clinicians, and functional experts from both institutions. By combining their knowledge and resources, they aim to accelerate the development and approval of next-generation AID systems.
Potential for Clinical Research and Improved Patient Outcomes
The results of this collaboration may lead to clinical research that could expedite the approval of Tandem's next-generation AID systems. This could potentially bring these advanced technologies to patients sooner, offering them greater freedom and improved glucose control.
A Shared Commitment to Improving Lives
Both the University of Virginia and Tandem Diabetes Care are deeply committed to improving the lives of people with diabetes. This research collaboration exemplifies their dedication to innovation and patient-centered care. By combining their expertise and resources, they are poised to make significant strides in diabetes management and bring about meaningful advancements in the field.
Tandem's Support for Diabetes Research
As part of the agreement, Tandem Diabetes Care will provide research funding, technology, and supplies to the University of Virginia. This support will enable the university to conduct diabetes-centered research and potential clinical studies, further contributing to the advancement of diabetes care.
Source: UVA Health